PharmaShots | Incisive News in 3 Shots

Subscribe Now

Phase 3

Merck and Ridgeback Initiate P-III MOVe-AHEAD Study of Molnupiravir for the Prevention of COVID-19 Infection

Merck and Ridgeback Initiate P-III MOVe-AHEAD Study of Molnupiravir for the Prevention of COVID-19 Infection

September 1, 2021

Janssen (J&J) Reports Results of Erleada (apalutamide) in P-III TITAN Study for Metastatic Castration-Sensitive Prostate Cancer (mCSPC) #ASCO2019

Janssen (J&J) Reports Results of Erleada (apalutamide) in P-III TITAN Study for Metastatic Castration-Sensitive Prostate Cance...

January 31, 2019

Celgene Reports Otezla (apremilast) Achieve 1EP in P-III STYLE Study to Treat Moderate-to-Severe Scalp Psoriasis

Celgene Reports Otezla (apremilast) Achieve 1EP in P-III STYLE Study to Treat Moderate-to-Severe Scalp Psoriasis

October 9, 2018

BioLineRx Annouces Positive Results for Phase 3 GENESIS Trial in Stem-Cell Mobilization

BioLineRx Annouces Positive Results for Phase 3 GENESIS Trial in Stem-Cell Mobilization

August 7, 2018

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us